The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo?
Communist China has the USA in a resource stranglehold. They have a monopoly on this CRITICAL metal that we desperately need for military technology. In fact, both Trump AND Biden passed executive orders that addressed this crisis. And it could have a massive effect on smart investor's bank accounts.
See This Growing National Security Threat Here
Dane C. Andreeff, insider at Helius Medical Technologies

Dane C. Andreeff Insider Information

Mr. Andreeff is the General Partner and Portfolio Manager of Maple Leaf Partners, L.P. and the President of Andreeff Equity Advisors, L.L.C. Mr. Andreeff has managed investment portfolios since 1996 for Andreeff Equity, L.P., Andreeff Overseas Ltd. and Clover Partners, LP. Prior to managing portfolios, Mr. Andreeff worked as an associate analyst at Furman Selz and Granite Capital International Group. Currently, Mr. Andreeff serves as a Director of TraceSecurity Inc., HDL Therapeutics, Inc. and Myocardial Solutions, Ltd.

Mr. Andreeff received his Master's degree in Economics from the University of Texas at Arlington in 1991 and Bachelor's degree in Economics from the University of Texas at Arlington in 1989.

How old is Dane C. Andreeff?

Mr. Andreeff is currently 56 years old. There are 3 older executives and no younger executives at Helius Medical Technologies. The oldest executive at Helius Medical Technologies is Mr. Jeffrey S. Mathiesen CPA, CPA, CFO, Treasurer, Sec. & Director, who is 61 years old. Learn More on Dane C. Andreeff's age.

How do I contact Dane C. Andreeff?

The corporate mailing address for Mr. Andreeff and other Helius Medical Technologies executives is 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940. Helius Medical Technologies can also be reached via phone at (215) 944-6100 and via email at [email protected] Learn More on Dane C. Andreeff's contact information.

Has Dane C. Andreeff been buying or selling shares of Helius Medical Technologies?

Dane C. Andreeff has not been actively trading shares of Helius Medical Technologies within the last three months. Most recently, on Friday, December 17th, Dane Andreeff bought 5,100 shares of Helius Medical Technologies stock. The stock was acquired at an average cost of $5.25 per share, with a total value of $26,775.00. Learn More on Dane C. Andreeff's trading history.

Who are Helius Medical Technologies' active insiders?

Helius Medical Technologies' insider roster includes Dane Andreeff (CEO), and Jeffrey Mathiesen (CFO). Learn More on Helius Medical Technologies' active insiders.

Are insiders buying or selling shares of Helius Medical Technologies?

In the last twelve months, Helius Medical Technologies insiders bought shares 3 times. They purchased a total of 45,600 shares worth more than $342,705.00. The most recent insider tranaction occured on December, 17th when CFO Jeffrey S Mathiesen bought 3,000 shares worth more than $15,930.00. Insiders at Helius Medical Technologies own 11.2 % of the company. Learn More about insider trades at Helius Medical Technologies.

Information on this page was last updated on 12/17/2021.

Dane C. Andreeff Insider Trading History at Helius Medical Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2021Buy5,100$5.25$26,775.00View SEC Filing Icon  
11/12/2021Buy37,500$8.00$300,000.00View SEC Filing Icon  
6/27/2018Buy10,000$10.10$101,000.00View SEC Filing Icon  
12/22/2017Buy255,101$1.96$499,997.96View SEC Filing Icon  
11/13/2017Buy167,000$2.58$430,860.00View SEC Filing Icon  
See Full Table

Dane C. Andreeff Buying and Selling Activity at Helius Medical Technologies

This chart shows Dane Andreeff's buying and selling at Helius Medical Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Helius Medical Technologies Company Overview

Helius Medical Technologies logo
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
Read More

Today's Range

Now: $0.52
Low: $0.52
High: $0.54

50 Day Range

MA: $1.30
Low: $0.48
High: $2.22

2 Week Range

Now: $0.52
Low: $0.45
High: $15.68

Volume

70,459 shs

Average Volume

4,729,065 shs

Market Capitalization

$1.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72
How High Can Copper Go?
To power the green revolution, copper demand continues to skyrocket with no end in sight. Prices hit a 10-year high; as copper jumped 79% in the past year. Some analysts are calling for copper to rise another 50-100%! We may be at the beginning of a copper bull run the likes we've never seen before. Just how high can copper go?
Find Out in this Research Report.